Empowered Patient Podcast

Karen Jagoda
  • ٤٫٩ (١٧)
  • طب
  • يتم التحديث يوميًا

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

  1. قبل ٢٢ ساعة · إضافة

    Using AI-Enhanced Mammography to See Through Dense Breast Tissue with Marissa Fayer DeepLook Medical TRANSCRIPT

    Marissa Fayer, CEO of DeepLook Medical, points out the challenges of detecting breast cancer in dense breast tissue using mammography. The DeepLook DP Precise platform is a visual intelligence tool designed to help radiologists see inside dense tissue more clearly, without disrupting their workflow and potentially reducing the need for additional tests or biopsies. A recent FDA mandate requiring providers to inform patients about their breast density has increased patient demand for better screening tools Marissa explains, "We're focused on breast imaging, and it's very specifically in dense breasts, because unfortunately, with dense, it's like seeing a cotton ball in the cloud. Radiologists have a really hard time seeing that in standard ways. This is a known problem. I developed the three mammography systems, so I absolutely know that it's a problem. We help radiologists visualize better with visual intelligence to be able to see inside these mammograms so that they potentially don't have to send their patients back for additional ultrasounds, other mammograms, or even biopsies." "So dense breasts show up white on mammograms, and cancer shows up white. So again, it's the analogy of the cotton bowl in the cloud. It might be there, but it might not be. The cloud is just hiding the cotton ball. This is just how X-ray technology is. It's been a problem and known since its inception, and unfortunately 45% to 50% of all women have dense breasts. And so, this is a very common problem, and there's nothing anybody can do. You can't diet or change the way your body composition is. In reality, this is just an additional add-on to existing screening that is a standard of care to help women."  #DeepLookMedical #WomenInHealthTech #BreastCancerAwareness #DenseBreastTissue #AIinHealthcare #DigitalHealth #HealthEquity #EarlyDetection #EmpoweredPatients #PatientCenteredCare #WomensHealth #Breastcancer deeplookmedical.com  Listen to the podcast here

  2. قبل ٢٣ ساعة

    Using AI-Enhanced Mammography to See Through Dense Breast Tissue with Marissa Fayer DeepLook Medical

    Marissa Fayer, CEO of DeepLook Medical, points out the challenges of detecting breast cancer in dense breast tissue using mammography. The DeepLook DP Precise platform is a visual intelligence tool to help radiologists see inside dense tissue more clearly without disrupting their workflow, potentially reducing the need for additional tests or biopsies. A recent FDA mandate requiring providers to inform patients about their breast density has increased patient demand for better screening tools Marissa explains, "We're focused on breast imaging, and it's very specifically in dense breasts, because unfortunately, with dense, it's like seeing a cotton ball in the cloud. Radiologists have a really hard time seeing that in standard ways. This is a known problem. I developed the three mammography systems, so I absolutely know that it's a problem. We help radiologists visualize better with visual intelligence to be able to see inside these mammograms so that they potentially don't have to send their patients back for additional ultrasounds, other mammograms, or even biopsies." "So dense breasts show up white on mammograms, and cancer shows up white. So again, it's the analogy of the cotton bowl in the cloud. It might be there, but it might not be. The cloud is just hiding the cotton ball. This is just how X-ray technology is. It's been a problem and known since its inception, and unfortunately 45% to 50% of all women have dense breasts. And so, this is a very common problem, and there's nothing anybody can do. You can't diet or change the way your body composition is. In reality, this is just an additional add-on to existing screening that is a standard of care to help women."  #DeepLookMedical #WomenInHealthTech #BreastCancerAwareness #DenseBreastTissue #AIinHealthcare #DigitalHealth #HealthEquity #EarlyDetection #EmpoweredPatients #PatientCenteredCare #WomensHealth #Breastcancer deeplookmedical.com Download the transcript here

    ١٧ من الدقائق

  3. قبل ٣ أيام · إضافة

    Remote Therapeutic Monitoring Through Daily Clinical Questions with Dan Cohen Adhere+ TRANSCRIPT

    Dan Cohen, President and Co-Founder of Adhere+, is advancing the role and function of remote therapeutic monitoring by asking patients a few questions every day through a smartphone app. Gathering this kind of data makes in-person visits with providers more productive and insightful. It helps providers manage chronic conditions and pain by using direct and indirect questions to gain a holistic view of the patient's overall well-being. This type of real-world data shows promise for enhancing clinical trials and powering AI-driven healthcare insights. Dan explains, "At its core, what we're doing is monitoring patients in between their visits with physicians. Now, I know a lot of your listeners have heard about telemedicine and telehealth, and sometimes they think they're the same thing, but they're not. Telemedicine is a synchronous communication where you'll be on your computer on a Zoom call with your doctor. That's telemedicine, where the physician is actually treating you as you would be in the office." "Telehealth is what happens in between physician meetings. It goes back to a very simple principle of medicine, something that physicians learn in the first two weeks of medical school. And that simple principle is the more often you touch a patient, the better the outcome is going to be. And in our telehealth approach using remote therapeutic monitoring, our physicians touch their patients every day for a brief few seconds to reinforce their care plan, to help the patients know that they're being treated, and for the patients to be able to act and react appropriately for their disease state." "The clinical questions are designed by clinicians around the country, and these questions change every day. They have normative ranges set in the background of those questions, and it really allows the physicians to drill down. We have default protocols, of course, to get practices started, and then physicians can titrate the questions to their needs. But if you think about the questions, it's the types of questions the physician is going to ask you when you're sitting in session with one another to try and find out what's happening."  #AdHerePlus #RTM #RemoteTherapeuticMonitoring #PainAwarenessMonth #USPain #ChangingthePainEquation #ChronicPain #DigitalHealth adhereplus.com Listen to the podcast here

  4. قبل ٣ أيام

    Remote Therapeutic Monitoring Through Daily Clinical Questions with Dan Cohen Adhere+

    Dan Cohen, President and Co-Founder of Adhere+, is advancing the role and function of remote therapeutic monitoring by asking patients a few questions every day through a smartphone app. Gathering this kind of data makes in-person visits with providers more productive and insightful. It helps providers manage chronic conditions and pain by using direct and indirect questions to gain a holistic view of the patient's overall well-being. This type of real-world data shows promise for enhancing clinical trials and powering AI-driven healthcare insights. Dan explains, "At its core, what we're doing is monitoring patients in between their visits with physicians. Now, I know a lot of your listeners have heard about telemedicine and telehealth, and sometimes they think they're the same thing, but they're not. Telemedicine is a synchronous communication where you'll be on your computer on a Zoom call with your doctor. That's telemedicine, where the physician is actually treating you as you would be in the office." "Telehealth is what happens in between physician meetings. It goes back to a very simple principle of medicine, something that physicians learn in the first two weeks of medical school. And that simple principle is the more often you touch a patient, the better the outcome is going to be. And in our telehealth approach using remote therapeutic monitoring, our physicians touch their patients every day for a brief few seconds to reinforce their care plan, to help the patients know that they're being treated, and for the patients to be able to act and react appropriately for their disease state." "The clinical questions are designed by clinicians around the country, and these questions change every day. They have normative ranges set in the background of those questions, and it really allows the physicians to drill down. We have default protocols, of course, to get practices started, and then physicians can titrate the questions to their needs. But if you think about the questions, it's the types of questions the physician is going to ask you when you're sitting in session with one another to try and find out what's happening."   #AdHerePlus #RTM #RemoteTherapeuticMonitoring #PainAwarenessMonth #USPain #ChangingthePainEquation #ChronicPain #DigitalHealth adhereplus.com Download the transcript here

    ٢٧ من الدقائق

  5. قبل ٤ أيام · إضافة

    Healthcare Investment Strategy Concentrates on Patient Outcomes with Sam Libby TCB Capital Advisors TRANSCRIPT

    Sam Libby is President and Managing Director of TCB Capital Advisors, a healthcare-focused investment and advisory firm with a focus on improving patient outcomes in oncology, neurodegenerative diseases, and women's health. The firm evaluates early-stage companies based on the strength of clinical data, scientific and medical expertise, and technology, which may have been overlooked or struggled to raise funding. Trends TCB is keeping an eye on include diagnostics and preventive healthcare, as well as the growing interest in women's health, an underinvested sector that presents significant opportunities for innovation and investment. Sam explains, "I think first and foremost, we look at the clinical data. So the way that we built TCD is that we have a team of experienced bankers and investors who work with early-stage companies. We also have on the other side of the house commercial experts and consultants who can do, I like to always say they can do all the things that bankers talk about. So, post-merger integration, building out the sales funnel, and applying for grants." "The other side, which I believe is probably the most important, is the scientific, strategic, and clinical advisory boards. And so when you're looking at one of these early-stage companies, the first thing is, does the science work? Is the actual foundation for the company solid? And so having experts that can drill into that because it's very easy when you start talking about deals and an early-stage company, everyone gets excited by the vision of the CEO or founder."  #TCBCapitalAdvisors #Healthcare #HeatlhcareInvestments #PatientOutcomes #Oncology #NeurodegenerativeDiseases #WomensHealth   TCBcapitaladvisors.com Listen to the podcast here

  6. قبل ٤ أيام

    Healthcare Investment Strategy Concentrates on Patient Outcomes with Sam Libby TCB Capital Advisors

    Sam Libby is President and Managing Director of TCB Capital Advisors, a healthcare-focused investment and advisory firm with a focus on improving patient outcomes in oncology, neurodegenerative diseases, and women's health. The firm evaluates early-stage companies based on the strength of clinical data, scientific and medical expertise, and technology, which may have been overlooked or struggled to raise funding. Trends TCB is keeping an eye on include diagnostics and preventive healthcare, as well as the growing interest in women's health, an underinvested sector that presents significant opportunities for innovation and investment. Sam explains, "I think first and foremost, we look at the clinical data. So the way that we built TCD is that we have a team of experienced bankers and investors who work with early-stage companies. We also have on the other side of the house commercial experts and consultants who can do, I like to always say they can do all the things that bankers talk about. So, post-merger integration, building out the sales funnel, and applying for grants." "The other side, which I believe is probably the most important, is the scientific, strategic, and clinical advisory boards. And so when you're looking at one of these early-stage companies, the first thing is, does the science work? Is the actual foundation for the company solid? And so having experts that can drill into that because it's very easy when you start talking about deals and an early-stage company, everyone gets excited by the vision of the CEO or founder."  #TCBCapitalAdvisors #Healthcare #HeatlhcareInvestments #PatientOutcomes #Oncology #NeurodegenerativeDiseases #WomensHealth   TCBcapitaladvisors.com Download the transcript here

    ٢٣ من الدقائق

  7. قبل ٥ أيام · إضافة

    Digital-First Dermatology Platform Expands Patient Access and Supports Independent Providers with Jon Friis Miiskin TRANSCRIPT

    Jon Friis, Founder and CEO of Miiskin, provides a telehealth platform to independent dermatologists and clinics, enabling them to serve a broader patient audience.  Using an asynchronous model, patients submit their images and medical history for the provider to review, and then receive a diagnosis and treatment plan within 24-48 hours.  This approach improves efficiency in handling routine care and prescription renewals, adds flexibility for patient convenience, and enables providers to allocate more time to address complex and high-value procedures.  Jon explains, "Miiskin's mission is to make high-quality dermatology care more accessible and convenient without compromising standards and care. We see ourselves as a differentiator in the market because we're enabling providers with a dermatology platform that they can use for their audience. They're not contracting with us as a provider. We enable the clinics and the providers with this technology platform. So we give the control back to the providers so they can meet the digital-first audience themselves and grow their business based on that." "With dermatology care, the skin is visible to the patient, and I strongly believe that the future will strive towards that. Every visit starts with the patient taking images and supporting patient information and patient history before they see any provider and consult with the provider. Therefore, it's essential that the cameras are of good quality, the images are of high quality, and the image capture process is. And that's where we've been evolving a lot of imaging technology to support that process for our platform and providers."  #Miiskin #DigitalDermatology #Dermatologist #Telehealth miiskin.com Listen to the podcast here

  8. قبل ٥ أيام

    Digital-First Dermatology Platform Expands Patient Access and Supports Independent Providers with Jon Friis Miiskin

    Jon Friis, Founder and CEO of Miiskin, provides a telehealth platform to independent dermatologists and clinics, enabling them to serve a broader patient audience.  Using an asynchronous model, patients submit their images and medical history for the provider to review, and then receive a diagnosis and treatment plan within 24-48 hours.  This approach improves efficiency in handling routine care and prescription renewals, adds flexibility for patient convenience, and enables providers to allocate more time to address complex and high-value procedures.  Jon explains, "Miiskin's mission is to make high-quality dermatology care more accessible and convenient without compromising standards and care. We see ourselves as a differentiator in the market because we're enabling providers with a dermatology platform that they can use for their audience. They're not contracting with us as a provider. We enable the clinics and the providers with this technology platform. So we give the control back to the providers so they can meet the digital-first audience themselves and grow their business based on that." "With dermatology care, the skin is visible to the patient, and I strongly believe that the future will strive towards that. Every visit starts with the patient taking images and supporting patient information and patient history before they see any provider and consult with the provider. Therefore, it's essential that the cameras are of good quality, the images are of high quality, and the image capture process is. And that's where we've been evolving a lot of imaging technology to support that process for our platform and providers."  #Miiskin #DigitalDermatology #Dermatologist #Telehealth miiskin.com Download the transcript here

    ١٧ من الدقائق
مشاهدة الكل (٢ ألف)

٤٫٩
من ٥
‫١٧ من التقييمات‬

حول

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

المعلومات

  • صناع العمل
    Karen Jagoda
  • سنوات النشاط
    ٢٠١٥ - ٢٠٢٥
  • الحلقات
    ٢ ألف
  • التقييم
    ملائم
  • حقوق النشر
    © 2024
  • موقع البرنامج على الويب
    Empowered Patient Podcast

قد يعجبك أيضًا